Results

Total Results: 460 records

Showing results for "vascular".

81. Stroke-Atrial-Fibrillation Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/stroke-atrial-fibrillation_executive.pdf
    August 01, 2013 - [2 points], Diabetes mellitus, prior Stroke/transient ischemic attack/ thromboembolism [2 points], Vascular … (2 points), Diabetes mellitus, prior Stroke/transient ischemic attack/thromboembolism (2 points), Vascular … All-cause mortality 1 (6,706) SOE = High No difference (HR 1.01; 95% CI 0.81 to 1.26) Death from vascular … = Low Trend toward a reduction in risk with apixaban (HR 0.79; 95% CI 0.62 to 1.02) Death from vascular … points), Diabetes mellitus, prior Stroke/transient ischemic attack/ thromboembolism (2 points), Vascular

82. Diagnostic Errors in the Emergency Department: A Systematic Review | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/diagnostic-errors-emergency/protocol
    December 21, 2020 - Informants, we anticipate the following clinical conditions to top the list of most frequent causes of harm: vascular … Serious misdiagnosis-related harms in malpractice claims: The "Big Three" - vascular events, infections … Rate of diagnostic errors and serious misdiagnosis-related harms for major vascular events, infections

83. Disposition of Comments for Treatment Strategies for Patients With Peripheral Artery Disease (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/peripheral-artery-disease-treatment_disposition-comments.pdf
    May 29, 2013 - Also, physiologic modifiers, such as anatomy, differences in vascular wall biology, hemostatic mechanisms … 1995, the routine use of statin therapy has reduced morbidity and mortality from CV and peripheral vascular … Member 4 Summary/Discussion/ Conclusion Page 144, line 26-may be helpful to again define "high- risk" vascular … We have deleted the phrase “high-risk vascular patient” and added phrases the reviewer correctly identified … Dietary cholesterol and egg yolks: Not for patients at risk of vascular disease.

84. Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/type-2-diabetes-medications-update_research-protocol.pdf
    April 06, 2010 - classified as macrovascular complications (such as incident coronary artery disease and events, peripheral vascular … classified as macrovascular complications (such as incident coronary artery disease and events, peripheral vascular … o We excluded biologic markers of outcomes, such as vascular endothelial function or carotid intima medial

85. Noninvasive Testing for Coronary Artery Disease (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/coronary-artery-disease-testing_research-protocol.pdf
    January 15, 2015 - responses through an imbalance of chemical mediators of vasorelaxation and vasoconstriction, termed vascular … The pathophysiologic changes in coronary artery anatomic structure (including deposition of plaque), vascular … include those related to local anesthesia and use of contrast material, as well as infection, local vascular … probable) • Possible ECG changes (e.g., T-wave, NSTEMI) or nondiagnostic ECG • Presence of other vascular … nephrogenic systemic fibrosis, contrast-related harms, adverse reactions to drugs for stress tests), vascular

86. Microsoft Word - finbody.doc (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/renal-artery-stenosis_research-2007.pdf
    January 01, 2007 - We combined search terms for renal artery stenosis, renal hypertension, and renal vascular disease, … Tier III Other comparative studies that compared angioplasty or vascular surgery to medical therapy … Renal artery stenosis: a common and important problem in patients with peripheral vascular disease. … Pillay WR, Kan YM, Crinnion JN, Wolfe JH, Joint Vascular Research Group. … Severity of renal vascular disease predicts mortality in patients undergoing coronary angiography.

87. Clopidogrel after Drug-Eluting Stent Implantation: Is current practice sufficient (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/stent-clopidogrel-practice_research.pdf
    March 01, 2009 - Eisenstein reported receiving research grants from Medtronic Vascular. Dr. … and Quality, Proctor and Gamble, Pfizer, Medtronic, Alexion Pharmaceuticals, Medicure, Medtronic Vascular … Califf reported research grants or contracts from Abbott Vascular Devices, Advanced Cardiovascular … valvular heart disease, third heart sound, history of cerebrovascular disease, history of peripheral vascular

88. Comparative Effectiveness of Dietary Supplement Versus No Dietary Supplement Use in Adults Taking Cardiovascular Drugs | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/dietary-supplements/research-protocol
    December 21, 2010 - Outcomes KQ 1 Clinical outcomes: Mortality All-cause mortality Vascular death Specific vascular … ischemia attack (TIA) Carotid artery disease (not measured by IMT or Doppler) Other Peripheral vascular … the AHRQ Methods Guide35 (for definitions, please see Section VI): KQ 1: Mortality (all-cause and vascular … (hemorrhagic/ischemic/unspecified stroke), quality of life, hospitalization, arrhythmia, peripheral vascular

89. Comparative Effectiveness of Pharmacologic and Mechanical Prophylaxis of Venous Thromboembolism Among Special Populations | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/vte-prophyalaxis/research-protocol
    January 12, 2012 - thromboembolism when anticoagulants are contraindicated Simon Nitinol® Permanent Bard Peripheral Vascular … Prevention of recurrent PE when anticoagulants are contraindicated G2® Retrievable Bard Peripheral Vascular … Prevention of recurrent PE G2x® Retrievable Bard Peripheral Vascular Prevention of recurrent … PE when anticoagulants are contraindicated Eclipse® Retrievable Bard Peripheral Vascular Prevention … thrombocytopenia Congenital platelet disorders VTE prophylaxis for long distance travel Abdominal surgery Vascular

90. Transparency of Reporting Requirements: Omega-3 Fatty Acids and Cardiovascular Disease (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/transparency-omega-3_research-protocol.pdf
    September 02, 2016 - [mp=ti, ot, ab, nm, hw, kw, kf, px, rx, ui, an, tx, sh, ct, bt, id, cc] 62. exp peripheral vascular … (peripheral and vascular and disease$).mp. … statin) O • Must mention CVD (or BP or lipids) in abstract • All-cause mortality • Cerebro/cardio-vascular … stroke/CVA, TIA, unstable angina, amputation 2° PVD, others o coronary/cardiac disease o peripheral vascular … cardiovascular invasive interventions (revascularization) § CABG (bypass), PCI (coronary angioplasty), vascular

91. Topic Suggestion Description | Effective Health Care Program
    effectivehealthcare.ahrq.gov/get-involved/nominated-topics/management-vestibular-schwannomas
    June 11, 2021 - Question 6: Does degree of vascular endothelial growth factor expression predict clinical behavior of

92. Management of Uterine Fibroids - Evidence Summary (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/evidence-summary-cer-195-uterine-fibroids-final.pdf
    December 01, 2017 - characteristics (e.g., age; race/ ethnicity; symptoms; menopausal status; imaging characteristics; vascular … characteristics (e.g., age; race/ethnicity; symptoms; menopausal status; imaging characteristics; vascular … Journal of vascular and interventional radiology : JVIR. 2014;25(6):823-832. 14. … Journal of vascular and interventional radiology : JVIR. 2011;22(9):1229-1235. 16. … Journal of vascular and interventional radiology : JVIR. 2005;16(11):1431-1437. 24.

93. Omega−3 Fatty Acids and Cardiovascular Disease: An Updated Systematic Review (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/fatty-acids-cardiovascular-disease_executive.pdf
    August 01, 2016 - may impact the purported CV benefits of n-3 FA, including lipid metabolism, blood pressure (BP) and vascular … reported in the previous review and expands the scope to include additional CVD outcomes (peripheral vascular … of quantiles) Outcomes • All-cause death • Cardiovascular (CV), cerebrovascular, and peripheral vascular … events: o Fatal vascular events (e.g., due to MI, stroke) o Total incident vascular events (e.g … � For peripheral vascular disease event, incident hypertension, MACE, and revascularization outcomes

94. Use of Antiplatelet Therapy in Patients Receiving Coronary Stents | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/coronary-stents-antiplatelet-therapy/abstract
    January 31, 2011 - Use of Antiplatelet Therapy in Patients Receiving Coronary Stents Research Report January 31, 2011 Findings from this study were published in the following journal articles. Tsai TT, Ho PM, Xu S, et al. Increased risk of bleeding in patients on clopidogrel therapy after drug-eluting stents implantatio…

95. Management of Infantile Hemangioma | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/infantile-hemangioma/clinician
    June 21, 2016 - Management of Infantile Hemangioma Clinician Summary Archived June 21, 2016 Download Main Document PDF 877.9 KB Archived: This report is greater than 3 years old. Findings may be used for research purposes, but should not be considered current.   Focus of This Summary This is a summary of a …

96. Treating Infantile Hemangiomas in Children | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/infantile-hemangioma/consumer
    June 21, 2016 - Treating Infantile Hemangiomas in Children Consumer Summary Archived June 21, 2016 Download Main Document PDF 3.5 MB Archived: This report is greater than 3 years old. Findings may be used for research purposes, but should not be considered current.   Is This Information Right for Me? This …

97. Diagnosis and Management of Infantile Hemangioma | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/infantile-hemangioma/research/

98. Topic Brief: Regenerative Medicine for Musculoskeletal (pdf file)
    effectivehealthcare.ahrq.gov/system/files/docs/topic-brief-regenerative-medicine-musculoskeletal.pdf
    January 01, 2021 - Intra-articular injection of autologous adipose-derived stromal vascular fractions for knee osteoarthritis … Outcomes After Intra-articular Injection With Adipose-Derived Cultured Stem Cells or Noncultured Stromal Vascular … Intratendinous adipose-derived stromal vascular fraction (SVF) injection provides a safe, efficacious

99. Topic Brief: Regenerative Medicine for Musculoskeletal (pdf file)
    effectivehealthcare.ahrq.gov/system/files/docs/topic-brief-regenerative-medicine-musculoskeletal_0.pdf
    January 01, 2021 - Intra-articular injection of autologous adipose-derived stromal vascular fractions for knee osteoarthritis … Outcomes After Intra-articular Injection With Adipose-Derived Cultured Stem Cells or Noncultured Stromal Vascular … Intratendinous adipose-derived stromal vascular fraction (SVF) injection provides a safe, efficacious

100. preoperative-testing-protocol-130514 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/preoperative-testing_research-protocol.pdf
     May 14, 2013 - minimally  invasive  through  high  risk,  maximally  invasive  surgeries  (e.g.,  vascular … Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular … Medicine and Biology, and Society for Vascular Surgery.